Lifecore Biomedical, Inc. (LFCR) Earnings History
Net Loss30 years of earnings data (1996–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Lifecore Biomedical, Inc. (LFCR) Earnings Overview
As of June 30, 2026, Lifecore Biomedical, Inc. (LFCR) reported trailing twelve-month net income of -$34M, reflecting -484.8% year-over-year growth. The company earned $-0.91 per diluted share over the past four quarters, with a net profit margin of -30.0%.
Looking at the long-term picture, LFCR's historical earnings data spans multiple years. The company achieved its highest annual net income of $29M in fiscal 2007.
Lifecore Biomedical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PCRX ($9M net income, 1.0% margin), HALO ($349M net income, 22.7% margin), ATRC (-$5M net income, -2.1% margin), LFCR has room to improve margins relative to the peer group. Compare LFCR vs PCRX →
LFCR Earnings vs Peers
Earnings metrics vs comparable public companies
LFCR Historical Earnings Data (1996–2025)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$39M | -422.3% | -$17M | $-1.27 | -30.0% | -13.4% |
| 2024 | $12M | +112.1% | -$9M | $0.33 | 9.4% | -6.9% |
| 2023 | -$100M | +14.7% | -$22M | $-3.32 | -96.4% | -21.1% |
| 2022 | -$117M | -261.4% | -$12M | $-3.97 | -104.9% | -10.6% |
| 2021 | -$32M | +15.4% | -$9M | $-1.12 | -32.0% | -8.7% |
| 2020 | -$38M | -1899.8% | -$26M | $-1.31 | -23.9% | -16.2% |
| 2019 | $2M | -91.5% | -$8M | $0.07 | 0.4% | -1.4% |
| 2018 | $25M | +134.5% | $12M | $0.89 | 4.7% | 2.3% |
| 2017 | $11M | +191.0% | $16M | $0.38 | 2.0% | 2.9% |
| 2016 | -$12M | -185.9% | -$20M | $-0.43 | -2.2% | -3.7% |
| 2015 | $14M | -29.3% | $18M | $0.50 | 2.5% | 3.4% |
| 2014 | $19M | -15.2% | $20M | $0.71 | 4.0% | 4.2% |
| 2013 | $23M | +77.9% | $25M | $0.85 | 5.1% | 5.6% |
| 2012 | $13M | +223.9% | $15M | $0.49 | 4.0% | 4.6% |
| 2011 | $4M | -1.6% | $8M | $0.15 | 1.4% | 2.9% |
| 2010 | $4M | -48.5% | $12M | $0.15 | 1.7% | 4.9% |
| 2009 | $8M | -42.9% | $13M | $0.29 | 3.3% | 5.3% |
| 2008 | $14M | -53.6% | $15M | $0.50 | 5.7% | 6.4% |
| 2007 | $29M | +237.4% | $30M | $1.07 | 13.9% | 14.4% |
| 2006 | $9M | +60.1% | $9M | $0.32 | 3.7% | 3.9% |
| 2005 | $5M | +86.3% | $6M | $0.21 | 2.6% | 2.9% |
| 2004 | $3M | +295.0% | $4M | $0.11 | 1.5% | 2.1% |
| 2002 | -$1M | +92.1% | $1M | $-0.08 | -0.8% | 0.7% |
| 2001 | -$19M | -369.9% | -$3M | $-1.15 | -9.8% | -1.4% |
| 2000 | -$4M | -42.8% | $-213,000 | $-0.25 | -1.9% | -0.1% |
| 1999 | -$3M | +3.4% | -$3M | $-0.28 | -7.9% | -8.8% |
| 1998 | -$3M | +66.3% | -$3M | $-0.22 | -8.7% | -9.9% |
| 1997 | -$9M | -104.8% | -$9M | $-0.77 | -90.5% | -94.7% |
| 1996 | -$4M | - | -$6M | $-0.54 | -168.0% | -224.0% |
Download Data
Export LFCR earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LFCR — Frequently Asked Questions
Quick answers to the most common questions about buying LFCR stock.
What is LFCR earnings per share (EPS)?
LFCR trailing twelve-month (TTM) diluted EPS is $-0.91, reflecting -484.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1996 to 2025 is available in the table on this page.
What is Lifecore Biomedical, Inc.'s net income?
Lifecore Biomedical, Inc. (LFCR) trailing twelve-month net income is $-34M as of 2025. Earnings declined -484.8% year-over-year.
Is LFCR profitable?
LFCR is not currently profitable on a TTM basis, reporting a net loss of $-34M. Net margin is -30.0%. Investors should monitor for a return to profitability.
What is LFCR's earnings growth rate?
LFCR compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2025.
What are LFCR's profit margins?
Lifecore Biomedical, Inc. net profit margin is -30.0%, operating margin is -13.4%, and gross margin is +31.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -612.1%.
Is LFCR growing earnings?
LFCR earnings are declining — EPS fell -484.8% year-over-year. TTM net income dropped to $-34M. This contrasts with the 5-year CAGR of N/A.
What was LFCR's best earnings year?
Lifecore Biomedical, Inc.'s highest annual net income on record is $29M, achieved in fiscal year 2007. Earnings history on this page spans 1996 to 2025 and includes all annual and quarterly figures.
What were LFCR's earnings last quarter?
LFCR's most recent reported quarter was Q3 2026. Net income was $-15M with diluted EPS of $-0.43. For a full breakdown of all quarters, see the quarterly earnings table on this page.